Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Halperin

Showing results (71-80 of 305) with videos related to

Pageof 31
Sort By:
Human Vaccines & Immunotherapeutics|February 11, 2015
Maintaining the momentum: key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemicBeth A Halperin, Donna MacKinnon-Cameron, Shelly McNeil, et al.
Protein Expression and Purification|September 5, 2006
Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coliMahdi Aminian, Sheila Sivam, Chiang W Lee, et al.
Human Vaccines|October 14, 2006
Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adultsScott A Halperin, Bruce Smith, Kevin Clarke, et al.
Infection and Immunity|March 26, 2003
Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric proteinSong F Lee, Scott A Halperin, Danny F Salloum, et al.
The Pediatric Infectious Disease Journal|July 3, 2008
Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007David W Scheifele, Julie A Bettinger, Scott A Halperin, et al.
Expert Review of Vaccines|May 11, 2013
Controlling serogroup B invasive meningococcal disease: the Canadian perspectiveJulie A Bettinger, Shelley L Deeks, Scott A Halperin, et al.
Plos One|December 5, 2024
An exploration of the role of trust and rapport in enhancing vaccine uptake among Anishinaabe in rural northern OntarioChris Sanders, Kristin Burnett, Lana Ray, et al.
BMJ Open|June 27, 2023
Identifying and addressing the impacts of the COVID-19 pandemic on school-based immunisation programmes in the Canadian Maritimes: a mixed methods study protocolAllyson J Gallant, Audrey Steenbeek, Scott A Halperin, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 20, 2007
Invasive pneumococcal infections in Canadian children, 1998-2003: implications for new vaccination programsJulie A Bettinger, David W Scheifele, Scott A Halperin, et al.
Vaccine|January 9, 2010
Pertussis immunization in paediatric healthcare workers: knowledge, attitudes, beliefs, and behaviourKarina A Top, Beth A Halperin, Darlene Baxendale, et al.
Pageof 31

Showing results (71-80 of 305) with videos related to

Sort By:
Pageof 31
Human Vaccines & Immunotherapeutics|February 11, 2015
Maintaining the momentum: key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemicBeth A Halperin, Donna MacKinnon-Cameron, Shelly McNeil, et al.
Protein Expression and Purification|September 5, 2006
Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coliMahdi Aminian, Sheila Sivam, Chiang W Lee, et al.
Human Vaccines|October 14, 2006
Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adultsScott A Halperin, Bruce Smith, Kevin Clarke, et al.
Infection and Immunity|March 26, 2003
Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric proteinSong F Lee, Scott A Halperin, Danny F Salloum, et al.
The Pediatric Infectious Disease Journal|July 3, 2008
Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007David W Scheifele, Julie A Bettinger, Scott A Halperin, et al.
Expert Review of Vaccines|May 11, 2013
Controlling serogroup B invasive meningococcal disease: the Canadian perspectiveJulie A Bettinger, Shelley L Deeks, Scott A Halperin, et al.
Plos One|December 5, 2024
An exploration of the role of trust and rapport in enhancing vaccine uptake among Anishinaabe in rural northern OntarioChris Sanders, Kristin Burnett, Lana Ray, et al.
BMJ Open|June 27, 2023
Identifying and addressing the impacts of the COVID-19 pandemic on school-based immunisation programmes in the Canadian Maritimes: a mixed methods study protocolAllyson J Gallant, Audrey Steenbeek, Scott A Halperin, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 20, 2007
Invasive pneumococcal infections in Canadian children, 1998-2003: implications for new vaccination programsJulie A Bettinger, David W Scheifele, Scott A Halperin, et al.
Vaccine|January 9, 2010
Pertussis immunization in paediatric healthcare workers: knowledge, attitudes, beliefs, and behaviourKarina A Top, Beth A Halperin, Darlene Baxendale, et al.
Pageof 31